Quetmolimab, CAS [[2084037-83-0]]

Produktübersicht

• Artikelname: Quetmolimab, CAS [[2084037-83-0]]
• Artikelnummer: MCE-HY-P99404
• Hersteller Artikelnummer: HY-P99404
• Alternativnummer: MCE-HY-P99404-10MG,MCE-HY-P99404-5MG,MCE-HY-P99404-1MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper
• Alternative Synonym: E6011

Produktbeschreibung

Quetmolimab (E6011) is a humanized anti-Fractalkine (CX3CL1) monoclonal antibody. Quetmolimab binds to membrane-bound and soluble Fractalkine, neutralizes Fractalkine-induced migration of CX3CR1-expressing cells, mediates target-bound complex elimination from serum. Quetmolimab suppresses free soluble Fractalkine levels in cynomolgus monkeys, with target engagement linked to increased serum total Fractalkine concentration. Quetmolimab can be used for the research of Crohns disease, rheumatoid arthritis, and primary biliary cholangitis[1].

Produkteigenschaften

• Molekulargewicht: (144.72 kDa)
• Reinheit: 99.90
• CAS Nummer: [2084037-83-0]
• Target-Kategorie: CXCR

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies